Q32 Bio Inc. (QTTB) › Operating IncomeQ32 Bio Inc. (QTTB) — Operating IncomeAnnual figures by period end, from SEC filings.2017-12-31: -$29.66M2018-12-31: -$59.93M2019-12-31: -$109.94M2020-12-31: -$130.26M2021-12-31: -$95.95M2022-12-31: -$133.28M2023-12-31: -$48.26M2024-12-31: -$66.10M2025-12-31: $16.90M$16.90M2017-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31$16.90M—2026-03-10From 2025-01-012024-12-31-$66.10M—2026-03-10From 2024-01-012023-12-31-$48.26M—2025-03-11From 2023-01-012022-12-31-$133.28M—2024-03-13From 2022-01-012021-12-31-$95.95M—2023-03-09From 2021-01-012020-12-31-$130.26M—2022-03-23From 2020-01-012019-12-31-$109.94M—2021-03-11From 2019-01-012018-12-31-$59.93M—2020-03-12From 2018-01-012017-12-31-$29.66M—2019-03-12From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)